News
Aprecia, the global leader in 3DP (three-dimensional print) technology for commercial-scale pharmaceutical manufacturing, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Hosted on MSN1mon
New FDA chief urges suspension of new regulatory fees - MSNThe Food and Drug Administration (FDA) has urged the Department of Health (DOH) to approve the immediate suspension of an order increasing the regulatory fees for registration and certification of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results